Previous reports suggest that a type II iodothyronine 5'-deiodinase may become the main enzymatic pathway for extrathyroidal triiodothyronine (T3) generation when the enzyme levels are sufficiently elevated and/or liver and kidney type I 5'-deiodinase activity is depressed. The present studies assessed the potential of brown adipose tissue (BAT) type II 5'-deiodinase to generate T3 for the plasma pool. BAT 5'-deiodination (BAT 5'D) was stimulated by either short-(4 h) or long-term (7 wk) cold exposure (40C). Long-term cold exposure increased thyroxine (T4) secretion 40-60% and extrathyroidal T3 production threefold. In cold-adapted rats treated with propylthiouracil (PTU), extrathyroidal T3 production was 10-fold higher than in PTUtreated rats maintained at room temperature. Cold did not stimulate liver or kidney 5'D, but the cold-adapted rats showed a six-to eightfold higher BAT 5'D content. PTU caused >95% inhibition of liver and kidney 5'D, but did not affect BAT 5'D.
Introduction
It is recognized that a large fraction of the circulating triiodothyronine (T3)' is generated extrathyroidally from thyroxine (T4) 5 'deiodination (1-3). T4 5'-deiodination is an enzyme-catalyzed reaction that takes place in several tissues. Largely because of the abundance of the enzyme in liver and kidney, these organs have been considered the main anatomic source of the extrathyroidally generated T3 (4) . The enzyme present in liver and kidney has received considerable attention over the last decade. The reaction is uncompetitively inhibited by propylthiouracil (PTU), which is postulated to react with the sulfenyl iodide complex formed in the reaction (5, 6) . The inhibition by PTU can be demonstrated either in vivo or in vitro (7, 8) . Reduced enzyme activity can be demonstrated in fasting, hypothyroidism, and during the fetal and early neonatal period (9) . We have termed this enzyme type I 5'-deiodinase (5'D-I).
PTU can decrease extrathyroidal T4 to T3 conversion by 60-70% in euthyroid rats (10, 1 1), but does not affect the acute inhibition of thyrotropin (TSH) release by T4 (11, 12) , or the pituitary and cerebral cortex content of ['25I ]T3 in animals injected with ['251 ]T4 (12, 13) . Altogether, these findings led to the discovery of a second enzymatic pathway for T4 5'-deiodination. The second enzyme, which we have termed type II 5'-deiodinase (5'D-II), when compared to SD-I, exhibits different kinetics, has an apparent Km for T4 that is at least 400-fold lower, is insensitive to PTU, increases markedly and rapidly after thyroidectomy, and is rapidly suppressed by the injection of thyroxine and its analogs (14) (15) (16) (17) (18) .
The failure to abolish extrathyroidal T4 to T3 conversion with PTU, along with the finding of a second pathway for T4 to T3 conversion, led us to reexamine the source of the extrathyroidally produced plasma T3. The studies showed that in adult and neonatal hypothyroid rats, all the T3 produced after a physiologic or a tracer dose ofT4 was generated via the 5D-II pathway (3, 19) . In 2-wk-old euthyroid rats, >80% of the plasma T3 generated from T4, as opposed to 30-40% in adult rats (10, 1 1, 13) , derived from 5'D-II activity (19) . Thus far, 5D-I had been found only in the central nervous system and the anterior pituitary, both of which seemed unlikely for generating circulating T3 from T4. The search for another anatomic source of T3 that could explain those findings, showed that brown adipose tissue (BAT) contained an enzyme that was indistinguishable from the 5D-II described in the central nervous system and adenohypophysis (20) . BAT 5 'D was also elevated in hypothyroid rats but, at variance with the pituitary and cerebral deiodinase, BAT 5D could be stimulated by the sympathetic nervous system as well (21) . More recently, Goswami and Rosenberg (22) have reported that, at low substrate concentration, kidney microsomes can catalyze 5'deiodination of T4 or reverse T3 (rT3) in the presence of 100 ,gM PTU, which opens the possibility of another "PTU-insensitive" extrathyroidal source of T3. However, neither the physiologic significance of their findings nor the physiologic responses of this enzyme have been established.
The goal of the experiments to be described was to assess the potential of BAT to produce T3 for the plasma pool. We have taken advantage of the possibility of manipulating the enzyme activity levels through the sympathetic nervous system and the relative insensitivity of the enzyme to inhibition by PTU. The results of the present study reveal that BAT 51D not only can produce significant amounts of T3 for the plasma pool, but also can augment markedly the T3 content of BAT itself.
Methods
These studies were performed on Sprague-Dawley rats obtained from Zivic-Miller Laboratories, (Allison Park, PA). At the beginning of the experiments the weight of the animal ranged from 75 to 100 g or 130 to 150 g as indicated. In some experiments, rats were thyroidectomized and placed on 0.5% calcium chloride in the drinking water. T4 was replaced as described along with the experiments. The rats were maintained at 23±10C or at 4±1 C as indicated in the text. They were given tap water and rat laboratory diet ad libitum, and were submitted to light cycles of 14 Collection ofsera and tissue samples. Rats were lightly anesthetized with ether, and 0.3-0.5 ml of blood was drawn from the heart at the indicated times after injecting its tracers. A blood sample was always obtained immediately before these injections. Rats were killed by exsanguination through the aorta under ether anesthesia. Interscapular BAT and aliquots of liver and kidney were collected for the measurement of either the content of labeled iodothyronines or 5'-deiodinases. The tissues were immediately frozen in dry ice/acetone and analyzed between 24 and 48 h of the experiment. The blood was allowed to clot, and the serum was collected and frozen until the measurements of labeled or unlabeled iodothyronines were performed.
Measurements of tracers in the serum. Serum ['25IT4 and ['3'I]T3 were separated and quantitated by paper chromatography (3, 19) . The origin of the Whatman 3 MM (Whatman, Inc., Clifton, NJ) was moistened with 25 ,ul of ethanol, and while wet, 20 zd of serum was applied followed by 50 ,ul of "marker" (-2 mg/ml T4, T3, and sodium iodide in ethanol made alkaline by adding 5% concentrated NH4OH). This volume of serum directly applied to the chromatography paper had no effect on the resolution ofthe major peaks of radioactivity (3, 19 (3, 12) . This latter correction factor was negligible by 4 h after the injection (3, 12) . The endogenously generated ['251JT3(T4) was then multiplied by 2 to correct for the halving of the T4 specific activity during conversion to T3. For Kinetic analysis. The experimental protocols are described with results. T4 and T3 clearances, fractional rates ofdisappearance from plasma, and fractional T4 to T3 conversion were calculated by noncompartmental analysis as described previously (3, 19) . Details applicable to the experiments are described along with the results. For convenience, in the studies to be described, the number of samples and the length of the interval of sampling were reduced to a minimum. This may result in some limitations in extrapolating the data to steady-state conditions, but it does not affect the conclusions of the present experiments.
Other procedures. Serum T4 and T3 concentrations were measured by previously described methods (30) . lodothyronine-stripped rat serum instead ofhuman serum was used for the standard curves in the radioimmunoassay.
Data were statistically analyzed by Student's t test and by one-or two-way analysis of variance, AOV and TWAOV, respectively. For multiple comparisons, when AOV indicated significant differences, the Newman-Keuls test was used (31) .
Results
Effects ofchronic cold exposure on thyroid hormone production and iodothyronine deiodinases. Euthyroid rats weighing 140±8 g (SEM) were divided into two groups. One was kept at -230C and the other at 4±1 0C for 7 wk. Both groups had free access to water and food, but the cold-exposed group gained less weight: at the end ofthe 7-wk period they weighed 425±18 g vs. 540±13 g (P < 0.001). At the end of 7 wks, one-half of the rats in each group were injected intraperitoneally with PTU 3 mg/100 g BW, 
where PRT3(T4) and PRT4 are the production rates of T3 from T4 and of T4, respectively; FC = fractional T4 to T3 conversion; and 651/777 a factor to correct for the change in molecular weight derived from the removal of one atom of iodine Table I . The data were analyzed by AOV and TWAOV. Cold exposure did not affect serum T4 concentrations, but serum T3 levels were elevated in cold-exposed animals. Cold exposure induced a modest but significant increment in T4 clearance, whereas that of T3 was not affected. PTU did not significantly affect the clearance of either hormone. T4 production rate and total T3 production were higher in cold-exposed rats (P < 0.001 and < 0.0025). Cold-acclimation also increased the fractional T4 to T3 conversion by threefold. Whereas in the rats maintained at 250C we observed the usual marked inhibition of T4 to T3 conversion by PTU (-75%), this was of less magnitude in the cold-exposed animals (-50%). The higher rates of fractional conversion of T4 to T3 and production of T4 in cold-exposed animals resulted in an approximate fourfold increment in extrathyroidal T3 production. Most notably, in the cold-exposed animals there was a 10-fold greater PTU-insensitive T3 generation from T4 than in the animals kept at normal ambient temperature.
It is important to stress that in these experiments the figures for production rates, fractional T4 to T3 conversion, and T3 secretion vs. extrathyroidal T3 production in the control animals are in good agreement with those previously reported (2, 3, 8) , in spite of the differences in age of the animals and the abbreviated period of sampling in the present experiments. In the cold-adapted rats, all the T3 production appears as extrathyroidal. This probably results from the accumulated dispersion of the data along the calculations which makes the thyroidal T3 secretion inapparent.
The effect of the cold and PTU on liver and kidney deio- dinases is shown in Table II . These assays were performed in the same animals 2 wk after the studies described above. The ambient conditions were rigorously maintained and PTU-but not the tracers-were administered in the same dosage schedule described. Low ambient temperature did not affect the enzyme levels in either tissue, whereas PTU inhibited the enzyme >98% in cold-exposed animals, as it does in rats at normal ambient temperature (3, 13) . BAT 5'deiodinase activities measured in the same rats are shown in Fig. 2 . The specific activity of the enzyme was about twofold increased in the cold-adapted animals and it was not affected by the PTU administration. Because of the twofold increment in BAT mass (763±74 vs. 354±64 mg, P < 0.001), the 2.3.fold increment in protein content (58±6 vs. 25±2 mg/g of BAT in the 1 ,500-g supernatant, P < 0.001), and the lower body weight of the cold-adapted animals, the BAT 5D per 100 g BW resulted greater than sixfold higher than in the room temperature controls. These changes in BAT mass and protein content have been reported previously (34) .
Effects of acute cold exposure on T3 production in thyroidectomized T-replaced PTU-treated rats. Effects ofa,-adrenergic blockade. The studies described above suggest that T3 production increases in cold adaptation, largely as a consequence of more active extrathyroidal T3 production and, further, that the enzymatic source is not the liver or kidney 5'D-I but more likely a tissue such as BAT containing a PTU-insensitive, cold-stimulated 5'deiodinase. The following experiments were performed to delineate more precisely the source of T3, i.e., to test the hypothesis as to whether the BAT 5'deiodinase was the source 2298 J. E. Silva (3, 19, 32) . Because the tracers were injected along with the daily replacement dose of T4, the T3 newly formed was calculated from the specific activity of the dose. The resulting figure does not represent the total production of T3 during this interval in that the amount of T4 remaining from previous doses was not taken into account. Rat weight at the time of injecting the tracers was 129±2 g (SEM) and the weight gain during the week oftreatment was 32±1 g, with no significant differences among the four groups. Similarly, serum T4 and T3 levels at this time did not differ among groups and were 1.7±0.09 (SEM) Ag/dl and 0.30±0.06 ng/ml, respectively. These are values obtained -24 h after the previous replacement dose. Sham thyroidectomized rats gained 39±11 g (n = 6), not significantly different from these rats, whereas untreated thyroidectomized rats, with undetectable serum T4, gained 15±3 g (P < 0.01). conversion by 70% at room temperature, as has been shown repeatedly (10, 11, 13) . In marked contrast, the PTU-treated rats exposed to cold did not show a reduction in fractional conversion when compared to controls at room temperature. In the cold-exposed PTU-treated animals, however, prazosin decreased fractional conversion by 87%. Because the fraction of the dose consumed during the interval of observation was not different, and the dose of T4 was the same from all the animals, the amounts of T3 produced and appearing in the plasma pool reflected basically the fractional conversions. In the cold-stressed PTU pretreated rats, the quantity of T3 produced was not different from control animals, and was greater than twofold higher than in PTU-treated rats maintained at room temperature (compare rows B and C in Table III) . Notably, 86% ofthis PTUinsensitive T3 production was eliminated by prazosin pretreatment.
The 5'deiodinase activities in BAT and liver in these animals are shown in higher in the cold-exposed PTU-treated rats than in the controls and eightfold greater than in the room temperature PTU-treated rats. The latter difference was abolished by pretreatment with prazosin. In contrast, the ['31I]T3, i.e., the T3 arriving in the tissue via plasma, was not higher in the cold-exposed PTU-treated rats. In the rats given prazosin, the higher [1311]T3 BAT content was a reflection of the higher serum levels, as shown in Fig. 4 . Note that the BAT/serum ratio was not different in this group (Table IV) .
The comparison of the BAT/serum ratios for [1251]T3(T4) and for [131I]T3 reveals highly significant differences. The higher is the former over the latter, the higher the fraction of locally produced T3 over plasma hormone T3. For convenience, the ratio of these two ratios has been entered as R in Table 4 . First, R was >1 in all four groups (P < 0.001 by paired t test). Secondly, R was the highest in cold-exposed PTU-treated animals which was entirely accounted for in a higher ['251 ]T3(T4) BAT/serum ratio than in other groups (P < 0.001). Thirdly, prazosin abolished these differences between cold-exposed rats maintained at room temperature. Altogether, these data indicate that there is a significant fraction of ['251 ]T3 in BAT that is unaccounted for by plasma T3, i.e., that is the result of local production. Furthermore, the locally produced T3 is markedly higher in animals acutely exposed to cold, a difference that is due to a PTU-insensitive, but prazosin-sensitive process, as is the stimulated BAT S'D enzyme activity (Fig. 5 ).
With the [13'I]T3 BAT/serum ratios and the plasma and tissue concentrations of ['251]T3(T4), one can calculate the fraction of the tissue [1251I]T3(T4) that has been locally produced (12) , which can also be readily obtained by computing (I-R-') from the R value shown in Table IV . One can also calculate the mass of T3 derived from the conversion. The results are shown in the last two columns of Table IV . PTU did not significantly reduce the total or locally generated T3 in BAT at room temperature. In rats treated with PTU, cold stress resulted in a fivefold greater amount of T3 locally generated from T4. 
Discussion
Our earlier studies in hypothyroid adult rats and neonatal rats, both euthyroid and hypothyroid, indicated that in these conditions a large fraction or all the T3 generated from T4 in the body was produced via a PTU-insensitive mechanism (3, 19 Our results showed that when animals are chronically exposed to low ambient temperature, there was an increased production of T4 and T3. Most relevant for the purpose of these studies, the extrathyroidal T3 production was about fourfold increased and, further, the PTU-insensitive extrathyroidal T3 production was augmented approximately 10-fold (Table I ). Increased plasma T3 concentrations or at least increased T3 to T4 ratios in circulation in rats exposed to cold have been previously reported (36) (37) (38) . The relative increment in T3 has been interpreted as due largely to T3 enrichment ofthe thyroidal secretion since this is seen after TSH stimulation and TSH is increased by cold stress (39) . More recently, Scammel et al. (40, 41) reported that liver and kidney deiodinase activities were increased in cold-exposed animals, and suggested that the mechanism was the elevated serum thyroxine derived from thyroidal secretion, i.e., that liver and kidney responses reflected the mild degree of hyperthyroidism of the cold-adapted animals. We were unable to reproduce their results because we found no increase in liver or kidney 5'deiodinase in rats exposed to cold for 7 wk (Table  II) . The explanation for the discrepancy is not readily apparent, although both the experimental protocol and the assay conditions were slightly different. Probably more significant is the fact that, even if those increments described by Scammell et al. (40, 41) were real, they do not seem enough to account for the increased fractional conversion and T3 production seen in the present studies. If To supplement the information provided by the first experiment, we explored in a more specific fashion the potential role of brown fat on T3 production during cold exposure. Some of the questions emerging from the first experiment were: the thyroidal secretion of T3, the enhanced liver and kidney 5'D-I activity reported by others in long-term cold exposure (40, 41) , and the specificity of BAT 5D-I as the source of PTU-insensitive T3-as opposed to other tissues containing S'D-II. To deal with these problems, we used thyroidectomized rats, we shortened the cold exposure, and we manipulated specifically BAT 5'D-II with prazosin. In addition, we looked at the BAT T3 content, because an increment of T3, if it was demonstrated to be produced locally, would be another feature favoring this tissue as a source of the increased plasma T3. Finally, the dose of PTU used in these experiments was the highest reported to the best ofour knowledge (10 mg/ 100 g of BW within 16 h) and certainly supramaximal for liver and kidney deiodinase inhibition (7, 13) . Notably, under these circumstances, a two-to threefold increase in PTU-insensitive T3 production was >85% reduced by pretreatment of the animals with prazosin. In addition, cold exposure resulted in a marked elevation of the concentration of T3 in the BAT, which was not accounted for by the increased plasma concentration and was abolished by treatment with prazosin. Both the findings in the plasma and in the BAT were paralleled by the changes in the BAT 5'deiodinase observed in these animals (Fig. 5) , whereas, regardless of the experimental condition, the liver 5'deiodinase was markedly reduced by PTU pretreatment. The results clearly demonstrate that BAT can produce significant amounts of T3, both for the tissue itself and for the plasma pool.
Although PTU has been one of our main tools to evaluate the origin of T3 in plasma and tissues (i.e. type I vs. type II T4 5'deiodinase) in these and in previous studies (3, 13, 19) , its use for this purpose in hypothyroxinemic states has recently been criticized on the grounds that the low substrate concentrations pertaining under these circumstances might make the "type I" enzyme less sensitive to PTU (22). This could occur if the postulated sulfenyl iodide complex of the type I enzyme were not available for interaction with PTU. Although we believe that there may be methodologic explanations for the apparent presence of a low Km, relatively PTU-insensitive, renal enzyme described by Goswami and Rosenberg (22), such arguments are not relevant to the present studies of BAT 5'deiodinase in rats with normal serum T4 concentrations and typical liver and kidney responses to PTU-induced inhibition of 5'deiodinase. Unlike the renal 5'deiodinase, BAT 5D-II is stimulated by cold, and its Vmax is increased, not decreased, in hypothyroidism (20, 21) . Unless the enzyme described by Goswami and Rosenberg (22) was increased in hypothyroidism, stimulated by the sympathetic nervous system, sensitive to inhibition by prazosin, and resistant to PTU inhibition under the conditions of the present experiments, the results shown here cannot be explained by that kidney enzyme.
The present findings have several important implications. First, they support the concept that the sympathetic nervous system and thyroid hormone act synergistically in the body to increase calorigenesis under some circumstances, e.g. cold adaptation. Secondly, these results add further support to the hypothesis that BAT may be an important source of T3 in hypothyroxinemia, as demonstrated by Lum et al. in humans (42) , and on the neonatal T3 surge, situations in which there is abundant BAT and increased sympathetic activity. Our estimate of a BAT T4 of 3 ng/g (Table V) indicates that this tissue compares in this respect favorably with liver and kidney (43) , also putative sources of plasma T3. It is true that the total body mass of BAT is less than the liver, and that the Vmax of BAT 5'D is markedly lower than liver and kidney 5D-I, but the catalytic efficiency of this Type II enzyme could compensate for this difference (14-16).
Lastly, the present findings suggest that thyroid hormone may be important for the function of the BAT and that we should revise the concept that thyroid hormone only plays a permissive role in the function of this tissue as heat dissipator, as suggested by Himms-Hagen (44). We have recently shown that the BAT 5D is under complex hormonal regulation (45) and, given the wide fluctuations ofthe enzyme activity, as shown in these and previous studies (19, 21, 45) , it is conceivable that the content of T3 in the BAT changes markedly without being reflected by the serum levels of T4 or T3, and vice versa, that marked fluctuations in serum levels of T4 or T3 are "buffered" by changes in BAT 5'D. Thus, when the animals are given just physiologic replacement doses of T4, and the brown fat is stimulated through the sympathetic nervous system, as done by Triandafillou et al. (45) , the content ofT3 ofthis tissue increases, as we have demonstrated in the present studies. Had the increment in BAT 5D not taken place, the possibility remains open that the calorigenic response of this tissue might have been less. Our results suggest that BAT, which is demonstrable in adult humans under some circumstances (47) , could play a role in the pathogenesis of obesity (48) and that alterations in BAT 5D could contribute to such alterations (49) .
